Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling road-segment-level speeding risk of new energy vehicle taxis using a multistage framework with spatial spillover, endogeneity, and nonlinear effects.

Accident; analysis and prevention·2026
Same author

Considering spatial heterogeneity in modeling taxi speeding frequency: An advanced geographically weighted negative binomial regression approach.

Accident; analysis and prevention·2025
Same author

Exploring the inter-relationship among hazardous actions, causal factors, and motorcyclist injury severity using path analysis.

Accident; analysis and prevention·2025
Same author

Bayesian survival analysis of interactions between truck platoons and surrounding vehicles through a two-dimensional surrogate safety measure.

Accident; analysis and prevention·2025
Same author

Identifying the reciprocal causation between hit-and-run behavior and crash injury severity.

Traffic injury prevention·2024
Same author

Analyzing the heterogenous effects of factors on high-range speeding likelihood of taxi speeders: Does explainable deep learning provides more insights than random parameter approach?

Accident; analysis and prevention·2024

Related Experiment Video

Updated: May 9, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Brain drug delivery systems

Xinguo Jiang

    Pharmaceutical Research
    |August 8, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
    05:44

    Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery

    Published on: November 14, 2018

    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
    08:25

    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

    Published on: July 16, 2014

    Related Experiment Videos

    Last Updated: May 9, 2026

    Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
    11:51

    Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

    Published on: August 16, 2010

    Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
    05:44

    Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery

    Published on: November 14, 2018

    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
    08:25

    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

    Published on: July 16, 2014